Aller au contenu
Force et musclesRevue des preuves3 min read

Sarcopenia linked to a higher hazard of hospitalisation in older people

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis. · BMC geriatrics · 2018 · Article original ↗

À retenir

Pooling 5 prospective cohort studies of 2832 older people, those with sarcopenia had a higher risk of hospitalisation (pooled hazard ratio 1.57, 95% CI 1.26 to 1.94). With only 5 studies, and no clear association in studies with under 3 years of follow-up, the finding is based on a thin evidence base.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Earlier cohort studies disagreed on whether sarcopenia, a loss of muscle mass and function, raises the risk of being hospitalised. The authors pooled the prospective evidence to find out whether sarcopenia predicts hospitalisation among older people.

Population et méthode

Systematic review and meta-analysis of prospective cohort studies that assessed sarcopenia and hospitalisation in older people, found by searching PubMed, EMBASE, Science Citation Index and the Cochrane Library. A random-effect model combined results according to the heterogeneity of the studies, with subgroup analyses by setting and length of follow-up. 5 studies with 2832 participants were included.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Older people with sarcopenia had a higher risk of hospitalisation than those without (pooled hazard ratio [HR] 1.57, 95% CI 1.26 to 1.94, I^(2) = 4.5%, P = 0.000), with very little heterogeneity.
  2. 2
    Among already hospitalised patients, sarcopenia was linked to a higher rate of hospitalisation (HR 2.01, 95% CI 1.41 to 2.88, p = 0.000).
  3. 3
    In community-dwelling older people the HR was 1.40 (95% CI 1.05 to 1.88, p = 0.023).
  4. 4
    With follow-up of 3 years or more, the pooled HR was 1.52 (95% CI 1.19 to 1.94, P = 0.001); with follow-up under 3 years it was 1.76 (95% CI 0.90 to 3.44, P = 0.099), which was not significant.

Limites et incertitude

  1. 1
    Only 5 studies contributed, so subgroup results rest on very few studies and estimates are wide, especially for follow-up under 3 years.
  2. 2
    Sarcopenia may be a marker of overall frailty or illness rather than the cause of hospitalisation; the abstract does not describe how well studies adjusted for other conditions.
  3. 3
    The authors say sarcopenia definition did not appear to change the association, but the abstract does not detail which definitions were used.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

Older people with sarcopenia are more likely to end up in hospital, so low muscle mass and strength are worth taking seriously. This is not proof that improving muscle would prevent admissions. Anyone worried about muscle loss or frailty should discuss assessment and exercise or nutrition plans with their clinician.

Vos données

A wearable cannot diagnose sarcopenia, which is defined by muscle mass and function. Daily steps, weight trends and simple repeated strength checks such as sit-to-stand or grip strength can help you notice a decline, compared on the same device and in the same way over months.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Previous cohort studies investigating the association between sarcopenia and the risk of hospitalization have been inconsistent. We performed a meta-analysis to determine if sarcopenia is a predictor of hospitalization.

Methods

Prospective cohort studies that evaluated the association between sarcopenia and hospitalization in older people were identified via a systematic search of four electronic databases (PubMed, EMBASE, Science Citation Index, and the Cochrane Library). A random-effect model was applied to combine the results according to the heterogeneity of the included studies.

Results

Five studies (2832 participants) were included in this meta-analysis. Pooled results demonstrated that older people with sarcopenia were at an increased risk of hospitalization (pooled hazards ratio [HR] = 1.57, 95% confidence interval [CI] = 1.26, 1.94, I^(2) = 4.5%, P = 0.000) compared to those without sarcopenia. Results of subgroup analyses showed that hospitalized patients with sarcopenia had a higher rate of hospitalization (HR = 2.01, 95% CI = 1.41, 2.88, p = 0.000) versus patients without sarcopenia. A similar result was also found in community-dwelling older people with sarcopenia versus those without sarcopenia (HR = 1.40, 95% CI = 1.05, 1.88, p = 0.023). In addition, the subgroup analysis for length of follow-up showed that studies with a follow-up period of 3 years or more (pooled HR = 1.52, 95% CI = 1.19, 1.94, P = 0.001) reported a significantly higher rate of hospitalization among individuals with sarcopenia compared to those without sarcopenia. However, this association was not found in the studies with a follow-up period of less than 3 years (pooled HR = 1.76, 95% CI = 0.90, 3.44, P = 0.099).

Conclusions

Sarcopenia is a significant predictor of hospitalization among older individuals, and the association may not be significantly affected by the characteristics of the population or the definition of sarcopenia.

Sources et attribution

Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis.

Zhang X, Zhang W, Wang C, Tao W, Dou Q, Yang Y.

BMC geriatrics · 2018-08-22

DOI: 10.1186/s12877-018-0878-0 ↗PubMed · 30134867 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Synthèse de revues

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse observationnelle

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
Force et muscles →